US 12098141
Bicyclic indazole glucocorticoid receptor antagonists
granted A61PA61P5/38
Quick answer
US patent 12098141 (Bicyclic indazole glucocorticoid receptor antagonists) held by Corcept Therapeutics Incorporated expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61P, A61P5/38